Suppr超能文献

重新评估ACEA 1021作为N-甲基-D-天冬氨酸受体士的宁不敏感甘氨酸位点拮抗剂的作用。

Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor.

作者信息

Lingenhöhl K, Pozza M F

机构信息

Novartis Pharma Inc., NS Research, Basel, Switzerland.

出版信息

Neuropharmacology. 1998 Jun;37(6):729-37. doi: 10.1016/s0028-3908(98)00062-8.

Abstract

Electrophysiological experiments were performed in vitro and in vivo to characterize the inhibitory effects of 6,7-dichloro-5-nitro-1,4-dihydro-2,3-quinoxalinedione (ACEA 1021; licostinel) on rat brain glutamate receptors. In vitro, ACEA 1021 was tested on N-methyl-D-aspartate (NMDA)-induced depolarizations in the neocortical slice preparation and on epileptiform activity in Mg2+-free hippocampal slices, which is known to be NMDA receptor mediated. In both in vitro models, ACEA 1021 exhibited antagonistic effects on the NMDA receptor-mediated responses. Selectivity tests in the neocortical slice preparation, using NMDA, kainate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) showed that 10 microM ACEA 1021 reduced NMDA and kainate responses to 27.9 and 79.9% of the control value, respectively, whereas responses to AMPA were increased by 2.4% above the control value, thus showing that at this concentration ACEA 1021 acts preferentially at NMDA receptors. However, at 30 microM, all the NMDA-, AMPA- and kainate-induced responses were reduced. In vivo, ACEA 1021 was tested on NMDA-induced excitation in the CA1 region. After systemic administration of ACEA 1021, central effects were observed at 10 mg/kg i.v. in the CA1 region. These results indicate that ACEA 1021 is centrally active and inhibits NMDA receptor-mediated responses. Interestingly, selectivity tests in the CA1 region did not show clear differences in the action of ACEA 1021 on NMDA- and AMPA-induced excitations. Furthermore, ACh-induced excitations were also reduced. Thus, at low concentrations, ACEA 1021 seems to be a selective antagonist at the strychnine-insensitive glycine site of the NMDA receptor. However, at 30 microM in vitro and at 10 mg/kg in vivo, non-NMDA receptor-mediated actions of ACEA 1021 are observed. Our results suggest that these additional effects of ACEA 1021 may contribute to its anticonvulsive properties in mice as well as to its neuroprotective properties in animal models of cerebral ischemia.

摘要

进行了体外和体内电生理实验,以表征6,7 - 二氯 - 5 - 硝基 - 1,4 - 二氢 - 2,3 - 喹喔啉二酮(ACEA 1021;利考斯汀)对大鼠脑谷氨酸受体的抑制作用。在体外,对新皮质切片制备中N - 甲基 - D - 天冬氨酸(NMDA)诱导的去极化以及无镁海马切片中的癫痫样活动进行了ACEA 1021测试,已知后者由NMDA受体介导。在这两种体外模型中,ACEA 1021均对NMDA受体介导的反应表现出拮抗作用。在新皮质切片制备中使用NMDA、海人酸和α - 氨基 - 3 - 羟基 - 5 - 甲基 - 4 - 异恶唑丙酸(AMPA)进行的选择性测试表明,10μM的ACEA 1021分别将NMDA和海人酸反应降低至对照值的27.9%和79.9%,而对AMPA的反应比对照值增加了2.4%,因此表明在此浓度下ACEA 1021优先作用于NMDA受体。然而,在30μM时,所有NMDA、AMPA和海人酸诱导的反应均降低。在体内,对CA1区域中NMDA诱导的兴奋进行了ACEA 1021测试。静脉注射10mg/kg的ACEA 1021后,在CA1区域观察到中枢效应。这些结果表明ACEA 1021具有中枢活性并抑制NMDA受体介导的反应。有趣的是,在CA1区域的选择性测试未显示ACEA 1021对NMDA和AMPA诱导的兴奋作用有明显差异。此外,乙酰胆碱诱导的兴奋也降低。因此,在低浓度下,ACEA 1021似乎是NMDA受体士的宁不敏感甘氨酸位点的选择性拮抗剂。然而,在体外30μM和体内10mg/kg时,观察到ACEA 1021的非NMDA受体介导的作用。我们的结果表明,ACEA 1021的这些额外作用可能有助于其在小鼠中的抗惊厥特性以及在脑缺血动物模型中的神经保护特性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验